next gen glp 1 FDA just approved orforglipron (Foundayo), Eli Lilly's oral GLP-1 receptor agonist for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest GLP-1 Collagen Peptides | Next-Gen

Zhang Y-Q, Sun B-Y, Dai J-J, Wu S-S, Zhang A-P, Zhao C-F, et al

2to analyze the relationships between plasma VPA concentrations and VPA-related effects on lactatemia

BPC-157 competition curves against [H]-VEGF binding demonstrate IC values in the nanomolar range across multiple cell line models

Supplementing with glutathione can help replenish these levels and support longevity from the inside out

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your genetic predispositions in key metabolic and GLP-1 pathway genes

What the research shows Studies examining GHK-Cu use over periods of 2-3 months consistently show favorable safety profiles